Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha Lipoic Acid for Ischemic Reperfusion Damage in Rat Priapism Model
NCT07391709Completed
- Sponsor
- Trabzon Kanuni Education and Research Hospital
- Start
- Feb 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of alpha-lipoic acid in Priapism and reperfusion injury (IRI) (3 arms), sponsored by Trabzon Kanuni Education and Research Hospital. Primary endpoints: Total Antioxidant Status at 7 days, Total Oxidant Status at 7 days and 3 more. Started Feb 2024; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
Priapismreperfusion injury (IRI)
Beyond the preview
Go deeper on NCT07391709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07391709.